Table 1.
BLSA, n = 1294 | Phenotyping, n = 640 | p-Valuea | |
---|---|---|---|
Male | 52.9% | 53.9% | NS |
White | 67.9% | 65.2% | <0.05 |
Baseline age (years) | 64.1 | 66.3 | <0.01 |
Baseline TSH (mIU/L) | 2.6 | 2.6 | NS |
Baseline fT4 (ng/dL) | 0.97 | 0.97 | NS |
Baseline fT3 (pg/mL) | 3.08 | 3.01 | <0.05 |
Education (high school grad) | 99.2% | 99.4% | NS |
Smoking (within 10 years) | 5.2% | 5.4% | NS |
Walking index | 8.4 | 8.4 | NS |
Self-rated health (SF-12) | 1.9 | 1.9 | NS |
Later levothyroxine useb | 5.0% | 3.8% | NS |
Body mass index | 27.1 | 26.9 | NS |
Active cohort | 75% | 82% | <0.01 |
Deceased | 13% | 10% | |
Lost to follow-up | 12% | 8% |
p-Values are derived using the chi-square test for categorical variables or two-sided t-test for continuous variables between included and excluded participants.
Participants can initiate thyroid hormone during observation; visits were censored once on therapy.
BLSA, Baltimore Longitudinal Study of Aging; TSH, thyrotropin; fT4, free thyroxine; fT3, free triiodothyronine; NS, not significant.